NEW YORK, Nov. 6, 2024 /PRNewswire/ -- Report with market evolution powered by AI - The global magnetic resonance imaging (MRI) coils market size is estimated to grow by USD 1.41 billion from ...

Influence of vascular comorbities and race on erectile dysfunction after prostate cancer radiotherapy. Background: One troubling aspect of active surveillance (AS) is that a subset of patients ...

The global MRI coils market is witnessing significant growth due to the rising adoption of advanced imaging technologies for diagnosing and monitoring a wide range of medical conditions. Magnetic ...

Multiparametric magnetic resonance imaging (mpMRI) is of interest for the diagnosis of clinically significant prostate cancer and mpMRI-targeted biopsies are being used increasingly in clinical ...

Multiparametric MRI (MP-MRI) administered as a triage test before a man's first transrectal ultrasound (TRUS) biopsy could identify at least one quarter of all patients who could safety avoid having a ...

This study is looking at 2 new ways of using an MRI scan to see changes in prostate cancer. It is open to men who have an intermediate risk or a high risk prostate cancer. This study is being done at ...

The image quality for detecting prostate cancer is significantly better for MRI at 1.5 T using an endorectal-body phased-array coil as compared with the 3.0 T imaging using the torso phased-array coil ...

availability of custom mri coils. However, high cost of MRI coils poses a challenge market players include Abbott Laboratories, Agilent Technologies Inc., AURORA HEALTHCARE US Corp., Bruker Corp., ...